Home > Back to Publisher > Report Information

The World Allergy Market 2006-2011: The Rx-OTC Rush

Visiongain
October 12, 2006
116 Pages - SKU: VSG1378402

Abstract Table of Contents Related Reports

Countries covered: Global

Why is the World Allergies Market Important?

The number of people suffering from some sort of allergy is on the rise and the demand for reliable treatments for allergic rhinitis and other allergic conditions is on the rise worldwide. The market is a mature one with a number of high profile patent losses in the near future and a strong OTC segment. Will there be a replacement for Zyrtec or Allegra in the near Future? What role will the new improved vaccines play in the next five years? Read visiongain’s new report to find out.

What is contained in the report?

The report covers all aspects of the current allergy market, including

A brief introduction into the biology of allergies
A market forecast for the world prescription market 2006-2011
Geographic breakdowns for sales revenues
A SWOT analysis of the allergic rhinitis market
Summaries and forecasts for the leading antihistamines and corticosteroids
An assessment of the drivers and restraints of the market
A discussion of the strategy of Rx-OTC switching
A review of the OTC market for allergic rhinitis
Analysis of treatments of eczema and allergic conjunctivitis

This report consists of over 100 pages and over 50 tables and figures.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Additional Information

Organisations Listed:

Alcon Inc
ALK-Abelló
Allergan
Allergy Therapeutics Plc
Astellas Pharma
AstraZeneca
Barr
Bausch & Lomb
Biogen Idec
Boehringer Ingelheim
Cambridge Antibody Technologies
Coley Pharmaceutical Group
Connetics
Curalogic
Cytos
Daiichi Sankyo
Dainippon Sumitomo
Elbion
Evolutec
GSK
H. Lundbeck
Inflazyme
Kyowa Hakko Kogyo
MedPointe Pharmaceuticals.
Merck and Co.
Mylan, Impax and Dr Reddy’s
Novartis
Pfizer
Prasco Labs
Rigel Pharmaceuticals
Sanofi-Aventis
Santen Pharmaceutical
Schering-Plough
Shionogi
Tanabe Seiyaku
Teva
UCB

1 Executive Summary: 1.1 Aims of the Report; 1.2 Summary of Contents
2 Introduction: 2.1 Allergies Defined and Explained; 2.2 Allergic Rhinitis; 2.3 Other Allergies; 2.4 The Epidemiology of Allergic Rhinitis; 2.5 The Treatment of Allergic Rhinitis; 2.6 Antihistamines and Corticosteroids are The Main Form of Treatment; 2.7 OTC Treatments are a Large Part of the Market; 2.8 Patent Expiry Will Be High But OTC Growth Will Soften the Blow; 2.9 Allergic Rhinitis Vaccines May Soon be Effective and Will Take Significant Market Share
3 The World Market for Allergic Rhinitis: 3.1 The World Prescription Market for Rhinitis Treatment Shows Steady Growth; 3.2 Prescription Drug Market Remains Steady Despite Patent Loss; 3.3 Antihistamines Remain the Principal Rhinitis Treatment; 3.4 The Growth of the OTC Market Will Continue; 3.5 Visiongain Predicts Negative Growth for the Total Allergic Rhinitis Market
4 The World Allergic Rhinitis Market by Geographic Region: 4.1 The US Dominates the Rx Market; 4.2 Europe Leads the OTC Market for Allergic Rhinitis; 4.3 Growth in the Developing Markets Will Remain Low
5 The World Antihistamine Market for Allergic Rhinitis: 5.1 Summary of the World Antihistamine Market, 2005; 5.2 The Entire Prescription Antihistamine Market is Facing Decline; 5.3 Zyrtex and Clarinex Face Imminent Patent Loss; 5.4 Other Brands Will Not Support the Market in the Future; 5.5 Other Brands are Growing but Revenues are Relatively Small; 5.6 Is OTC Switching a Viable Future Strategy for the Ailing Antihistamine Market?
6 The World Steroid Market for Allergic Rhinitis: 6.1 Summary of the World Corticosteroid Market, 2005; 6.2 World Steroids Market to Hold Steady Until 2011; 6.3 Conclusion: The World Market for Nasal Corticosteroids Will Maintain Value Due to Sales of Nasonex
7 The World OTC Market for Allergic Rhinitis: 7.1 New Switches and New Formulations Drive OTC Revenue Growth; 7.2 OTC Switches are Favoured by Insurers and Health Services; 7.3 Pharmacist Recommendations are Key in OTC Allergy Products; 7.4 The OTC Market Will Peak in 2008
8 SWOT Analysis of the Allergic Rhinitis Market: 8.1 Summary of Strengths, Weaknesses, Opportunities and Threats; 8.2 High Prevalence Drives the Market; 8.3 Low Rate of Adverse Effects is a Clear Advantage; 8.4 Anti-allergy Drugs are Obvious Targets for OTC Switching; 8.5 There are Disadvantages of OTC Dominance; 8.6 Generic Companies Will Target Allergic Rhinitis Treatments; 8.7 The OTC Decision is Key for the Allergic Rhinitis Market; 8.8 Unmet Needs: Persistent Sufferers Require Reliable and Convenient Treatments
9 Future Developments: 9.1 New Takes on Established Treatments Will Help Stem the Tide After Patent Loss; 9.2 Immunotherapy Aims to Meet Unmet Needs; 9.3 Development of New Asthma Treatments Will Lead to a New Allergy Drugs
10 Other Allergy Drugs: 10.1 Allergic Conjunctivitis; 10.2 Atopic dermatitis
11 Conclusion: A Mature Market in Need of Innovation: 11.1 The Allergy Market is Divided Into Sub-markets; 11.2 OTC May be the Answer For Some But Not All; 11.3 The Use of Vaccines is Set to Increase
List of Figures: Figure 3.1, Total Revenues ($m) for the Top Ten Allergic Rhinitis Treatments, 2004-2005; Figure 3.2, Growth Rates (%) for the Top Ten Allergic Rhinitis Treatments, 2004-2005; Figure 3.3, Allergic Rhinitis Market Share by Brand, 2005; Figure 3.4, Allergic Rhinitis Market Share by Mode of Action, 2005; Figure 3.5, Growth Rates (%) for Allergic Rhinitis Treatments by Mode of Action, 2004-2005; Figure 3.6, Total Schering Plough Revenues for Claritin, 2002-2005; Figure 5.1, Market Share by Drug for Antihistamines, 2005; Figure 5.2, World Revenues for Prescription Antihistamines, 2004-2011; Figure 5.3, Revenue Forecast for Zyrtec, 2005-2011; Figure 5.4, Revenue Forecast for Allegra, 2005-2011; Figure 5.5, Revenue Forecast for Clarinex, 2005-2011; Figure 5.6, Revenue Forecast for Claritin, 2005-2011; Figure 5.7, Revenue Forecast for Xyzal, 2005-2011; Figure 5.8, Revenue Forecast for Allelock, 2005-2011; Figure 5.9, Revenue Forecast for Other Branded Antihistamines, 2005-2011; Figure 6.1, Leading Nasal Corticosteroids by Market Share, 2005; Figure 6.2, World Revenue Forecast for the Leading Corticosteroids, 2005-2011; Figure 6.3, Revenue Forecast for Flonase, 2005-2011; Figure 6.4, Revenue Forecast for Nasonex, 2005-2011; Figure 6.5, Revenue Forecast for Rhinocort, 2005-2011; Figure 6.6, Revenue Forecast for Nasacort, 2005-2011; Figure 7.1, Brands Recommended by Pharmacists, 2005; Figure 8.1, Branded Drugs Facing Generic Compeition, 2005-2011; Figure 10.1, Revenues ($m) for Leading Atopic Dermatitis Treatments, 2005; Figure 10.2, Market Share for Leading Atopic Dermatitis Treatments, 2005
List of Tables: Table 3.1, Total Revenues and Growth Rates of Leading Allergic Rhinitis Treatments, 2004-2005; Table 3.2, US Patent Expiry Dates for Selected Allergic Rhinitis Treatments, 2006; Table 3.3, Antihistamines and Their Follow-Up Products, 2006; Table 3.4, Total Schering Plough Revenues for Claritin, 2002-2005; Table 3.5, World Market Forecast for Allergic Rhinitis Treatments, 2004-2011; Table 4.1, Market Share for Allergic Rhinitis by Country, 2005; Table 4.2, Allergic Rhinitis Markets in Selected Developing Countries, 2005; Table 5.1, Leading Prescription Antihistamines, 2005; Table 5.2, Forecast Revenues for Antihistamines, 2004-2011; Table 5.3, Revenue Forecast for Zyrtec, 2004-2011; Table 5.4, Revenue Forecast for Allegra, 2004-2011; Table 5.5, Revenue Forecast for Clarinex, 2004-2011; Table 5.6, Revenue Forecast for Claritin, 2004-2011; Table 5.7, Revenue Forecast for Xyzal, 2004-2011; Table 5.8, Revenue Forecast for Allelock, 2004-2011; Table 6.1, Leading Prescription Nasal Corticosteroids, 2005; Table 6.2, World Revenue Forecast for the Leading Corticosteroids, 2004-2011; Table 6.3, Combined Q1 and Q2 Revenues For Flonase, 2006; Table 6.4, Revenue Forecast for Flonase, 2004-2011; Table 6.5, Revenue Forecast for Nasonex, 2004-2011; Table 6.6, Revenue Forecast for Rhinocort, 2004-2011; Table 6.7, Revenue Forecast for Nasacort, 2004-2011; Table 7.1, Candidates for Rx-OTC Switching; Table 8.1, Summary of Strengths, Weaknesses, Opportunities and Threats for the Allergic Rhinitis Market; Table 9.1, Combination Therapies and Follow-on Products in the Pipeline, 2006; Table 9.2, Immunotherapy Products in the Pipeline, 2006; Table 9.3, Pipeline Drugs Indicated for Asthma and Allergic Rhinitis, 2006; Table 10.1, Treatments for Allergic Conjunctivitis; Table 10.2, Leading Treatments for Atopic Dermatitis, 2005; Table 11.1, Selected Allergy Vaccines in Development

More Global Allergy/Immunology Reports

The World Market for Over The Counter (OTC) Drugs by Kalorama Information
Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. Many pharmaceutical companies seeking more revenue and ...

Nasal Congestion Global Clinical Trials Review, H1, 2012 by GlobalData
Nasal Congestion Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Nasal Congestion Global Clinical Trials Review, H1, 2012 provides data on the Nasal Congestion ...

Food Allergy and Intolerance Products by Global Industry Analysts
This report analyzes the worldwide markets for Food Allergy and Intolerance Products in US$ Million by the following product segments: Gluten-free, and Others. The report ...

The 2011-2016 World Outlook for Non-Prescription Decongestants Excluding Nasal Sprays and Nose Drops by Icon Group International, Inc.
This econometric study covers the world outlook for non-prescription decongestants excluding nasal sprays and nose drops across more than 200 countries. For each year reported, ...

Nicholas Hall's Global Cough, Cold & Allergy Review by Nicholas Hall and Company
This essential report is the ideal guide to CCA brands and marketers across leading developed and emerging markets, focusing on core trends and exciting developments. ...

See all reports like this >>

The World Allergy Market 2006-2011: The Rx-OTC Rush

Share this report

Other tasks

Research Assistance

Related Markets

Allergy/Immunology Reports

Free Alert Me service